Impact of Medication Regimen Simplification on Medication Adherence and Clinical Outcomes in Patients with Long-Term Medical Conditions

References

• Fischer MA, Stedman MR, Lii J, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284–290. doi:10.1007/s11606-010-1253-9
   PubMed Web of Science ®Google Scholar
• Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–1841. doi:10.1001/archinte.166.17.1836
   PubMed Web of Science ®Google Scholar
• de Vries ST, Keers JC, Visser R, et al. Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes. J Psychosom Res. 2014;76(2):134–138. doi:10.1016/j.jpsychores.2013.11.003
   PubMed Web of Science ®Google Scholar
• Elliott RA. Reducing medication regimen complexity for older patients prior to discharge from hospital: feasibility and barriers. J Clin Pharm Ther. 2012;37(6):637–642. doi:10.1111/j.1365-2710.2012.01356.x
   PubMed Web of Science ®Google Scholar
• Kerwin EM, Nathan RA, Meltzer EO, et al. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg diskus administered once daily. Respir Med. 2008;102(4):495–504. doi:10.1016/j.rmed.2007.12.002
   Web of Science ®Google Scholar
• Ma A, Chen DM, Chau FM, Saberi P. Improving adherence and clinical outcomes through an HIV pharmacist’s interventions. AIDS Care. 2010;22(10):1189–1194. doi:10.1080/09540121003668102
   PubMed Web of Science ®Google Scholar
• Stange D, Kriston L, Von-Wolff A, Baehr M, Dartsch DC. Reducing cardiovascular medication complexity in a German University Hospital: effects of a structured pharmaceutical management intervention on adherence. J Manag Care Pharm. 2013;19(5):396–407.
   PubMed Web of Science ®Google Scholar
• Benner JS, Chapman RH, Petrilla AA, Tang SSK, Rosenberg N, Schwartz JS. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. Am J Health Pharm. 2009;66(16):1471–1477. doi:10.2146/ajhp080238
   PubMed Web of Science ®Google Scholar
• Witticke D, Seidling HM, Lohmann K, Send AFJ, Haefeli WE. Opportunities to reduce medication regimen complexity: a retrospective analysis of patients discharged from a University Hospital in Germany. Drug Saf. 2013;36(1):31–41. doi:10.1007/s40264-012-0007-5
   Web of Science ®Google Scholar
• Pauly A, Wolf C, Mayr A, Lenz B, Kornhuber J, Friedland K. Effect of a multi-dimensional and inter-sectoral intervention on the adherence of psychiatric patients. PLoS One. 2015;10(10):1–18. doi:10.1371/journal.pone.0139302
   Web of Science ®Google Scholar
• Corsonello A, Pedone C, Lattanzio F, et al. Regimen complexity and medication nonadherence in elderly patients. Ther Clin Risk Manag. 2009;5(1):209–216. doi:10.2147/tcrm.s4870
   PubMedGoogle Scholar
• Choudhry NK, Fischer MA, Avorn J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011;171(9):814–822. doi:10.1001/archinternmed.2010.495
   PubMedGoogle Scholar
• Barnebey HS, Robin AL. Adherence to fixed-combination versus unfixed travoprost 0.004%/timolol 0.5% for glaucoma or ocular hypertension: a randomized trial. Am J Ophthalmol. 2017;176:61–69. doi:10.1016/j.ajo.2016.12.002
   PubMed Web of Science ®Google Scholar
• Laliberte F, Bookhart BK, Nelson WW, et al. Impact of once-daily versus twice-daily dosing frequency on adherence to chronic medications among patients with venous thromboembolism. Patient. 2013;6(3):213–224. doi:10.1007/s40271-013-0020-5
   PubMedGoogle Scholar
• Rubio R, Serrano O, Carmena J, et al. Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions. HIV Med. 2010;11(9):545–553. doi:10.1111/j.1468-1293.2010.00827.x
   Web of Science ®Google Scholar
• Buscher A, Hartman C, Kallen MA, Giordano TP. Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naïve HIV patients. Int J STD AIDS. 2012;23(5):351–355. doi:10.1258/ijsa.2011.011292
   PubMed Web of Science ®Google Scholar
• Palella FJ, Fisher M, Tebas P, et al. Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants. AIDS. 2014;28(3):335–344. doi:10.1097/QAD.0000000000000087
   PubMed Web of Science ®Google Scholar
• Fabbiani M, Zaccarelli M, Grima P, et al. Single tablet regimens are associated with reduced efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients. BMC Infect Dis. 2014;14(1):1–8. doi:10.1186/1471-2334-14-26
   Web of Science ®Google Scholar
• Hernández Arroyo MJ, Cabrera Figueroa SE, Sepúlveda Correa R, Valverde Merino MP, Luna Rodrigo G, Domínguez-Gil Hurlé A. Influence of the number of daily pills and doses on adherence to antiretroviral treatment: a 7-year study. J Clin Pharm Ther. 2016;41(1):34–39. doi:10.1111/jcpt.12343
   PubMed Web of Science ®Google Scholar
• Velvanathan T, Islahudin F, Sim BLH, Taha NA. Simplification of HAART therapy on ambulatory HIV patients in Malaysia: a randomized controlled trial. Pharm Pract (Granada). 2016;14(4):1–8. doi:10.18549/PharmPract.2016.04.830
   Google Scholar
• Chen Y, Chen K, Kalichman SC. Barriers to HIV medication adherence as a function of regimen simplification. Ann Behav Med. 2017;51(1):67–78. doi:10.1007/s12160-016-9827-3
   PubMed Web of Science ®Google Scholar
• Furtado Dos Santos S, Almeida-Brasil CC, Costa JDO, et al. Does switching from multiple to single-tablet regimen containing the same antiretroviral drugs improve adherence? A group-based trajectory modeling analysis. AIDS Care. 2020:1–9. doi:10.1080/09540121.2020.1736258
   Web of Science ®Google Scholar
• Taybani Z, Bótyik B, Katkó M, Gyimesi A, Várkonyi T. Simplifying complex insulin regimens while preserving good glycemic control in type 2 diabetes. Diabetes Ther. 2019;10(5):1869–1878. doi:10.1007/s13300-019-0673-8
   PubMed Web of Science ®Google Scholar
• Dudl RJ, Wang MC, Wong M, Bellows J. Preventing myocardial infarction and stroke with a simplified bundle of cardioprotective medications. Am J Manag Care. 2009;15(10):88–94.
   Web of Science ®Google Scholar
• Oh CK, Bang JB, Kim SJ, et al. Improvement of medication adherence with simplified once-daily immunosuppressive regimen in stable kidney transplant recipients: a prospective cohort study. Asian J Surg. 2020;43(6):660–667. doi:10.1016/j.asjsur.2019.07.011
   Web of Science ®Google Scholar
• Sluggett JK, Hopkins RE, Chen EY, et al. Impact of medication regimen simplification on medication administration times and health outcomes in residential aged care: 12 month follow up of the SIMPLER randomized controlled trial. J Clin Med. 2020;9(4):1053. doi:10.3390/jcm9041053
   Web of Science ®Google Scholar
• Alves-Conceição V, Rocha KSS, Silva FVN, et al. Are clinical outcomes associated with medication regimen complexity? A systematic review and meta-analysis. Ann Pharmacother. 2020;54(4):301–313. doi:10.1177/1060028019886846
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Nuckols TK, Coles C, et al. A systematic overview of systematic reviews evaluating medication adherence interventions. Am J Health Pharm. 2020;77(2):138–147. doi:10.1093/ajhp/zxz284
   PubMed Web of Science ®Google Scholar
• Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008;31(3):213–224. doi:10.1007/s10865-007-9147-y
   PubMed Web of Science ®Google Scholar
• Pantuzza LL, Ceccato MDGB, Silveira MR, Junqueira LMR, Reis AMM. Association between medication regimen complexity and pharmacotherapy adherence: a systematic review. Eur J Clin Pharmacol. 2017;73(11):1475–1489. doi:10.1007/s00228-017-2315-2
   PubMed Web of Science ®Google Scholar
• Pellock JM, Smith MC, Cloyd JC, Uthman B, Wilder BJ. Extended-release formulations: simplifying strategies in the management of antiepileptic drug therapy. Epilepsy Behav. 2004;5(3):301–307. doi:10.1016/j.yebeh.2004.01.009
   PubMed Web of Science ®Google Scholar
• Suzuki T, Uchida H, Takeuchi H, et al. Simplifying psychotropic medication regimen into a single night dosage and reducing the dose for patients with chronic schizophrenia. Psychopharmacology (Berl). 2005;181(3):566–575. doi:10.1007/s00213-005-0018-3
   Web of Science ®Google Scholar
• Roitman JL, Kalra S. Interventions to improve adherence to lipid lowering medication. J Cardiopulm Rehabil Prev. 2007;27(2):115. doi:10.1097/01.hcr.0000265040.54651.64
   Google Scholar
• Leichter SB, Thomas S. Combination medications in diabetes care: an opportunity that merits more attention. Clin Diabetes. 2003;21(4):175–178. doi:10.2337/diaclin.21.4.175
   Google Scholar
• Poulter NR, Borghi C, Parati G, et al. Medication adherence in hypertension. J Hypertens. 2020;38(4):579–587. doi:10.1097/HJH.0000000000002294
   PubMed Web of Science ®Google Scholar
• Hung TC, Chen GJ, Cheng SH, et al. Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression. J Microbiol Immunol Infect. 2019;52(6):865–871. doi:10.1016/j.jmii.2019.07.002
   Google Scholar
• Finitsis D, Pellowski J, Huedo-Medina T, Fox MC, Kalichman SC. Visual analogue scale (VAS) measurement of antiretroviral adherence in people living with HIV (PLWH): a meta-analysis. J Behav Med. 2016;39(6):1043–1055. doi:10.1007/s10865-016-9770-6
   PubMed Web of Science ®Google Scholar
• Pan F, Chernew ME, Fendrick AM. Impact of fixed-dose combination drugs on adherence to prescription medications. J Gen Intern Med. 2008;23(5):611–614. doi:10.1007/s11606-008-0544-x
   PubMed Web of Science ®Google Scholar
• Chien HH, Chang CT, Chu NF, et al. Effect of glyburide-metformin combination tablet in patients with type 2 diabetes. J Chin Med Assoc. 2007;70(11):473–480. doi:10.1016/S1726-4901(08)70044-3
   PubMedGoogle Scholar
• Dickson M, Plauschinat CA. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy. Am J Cardiovasc Drugs. 2008;8(1):45–50. doi:10.2165/00129784-200808010-00006
   PubMed Web of Science ®Google Scholar
• Gerbino PP, Shoheiber O. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am J Health Pharm. 2007;64(12):1279–1283. doi:10.2146/ajhp060434
   PubMed Web of Science ®Google Scholar
• Roca B, Lapuebla C, Vidal-Tegedor B. HAART with didanosine once versus twice daily: adherence and efficacy. Int J Infect Dis. 2005;9(4):195–200. doi:10.1016/j.ijid.2004.07.006
   Web of Science ®Google Scholar
• Kuna P, Creemers JPHM, Vondra V, et al. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma. Respir Med. 2006;100(12):2151–2159. doi:10.1016/j.rmed.2006.03.016
   Web of Science ®Google Scholar
• Caldeira D, Vaz-Carneiro A, Costa J. The impact of dosing frequency on medication adherence in chronic cardiovascular disease: systematic review and meta-analysis. Rev Port Cardiol (English Ed. 2014;33(7–8):431–437. doi:10.1016/j.repce.2014.01.014
   Google Scholar
• George J, Elliott RA, Stewart DC. A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications. Drugs Aging. 2008;25(4):307–324. doi:10.2165/00002512-200825040-00004
   PubMed Web of Science ®Google Scholar
• Jarab A, Mukattash T, Hilan H. Medication non-adherence in patients with osteoporosis: implications for clinical pharmacists and osteoporosis care providers. Curr Clin Pharmacol. 2020;15:1–8. doi:10.2174/1574884715666200116104754
   Web of Science ®Google Scholar
• Iglay K, Cao X, Mavros P, Joshi K, Yu S, Tunceli K. Systematic literature review and meta-analysis of medication adherence with once-weekly versus once-daily therapy. Clin Ther. 2015;37(8):1813–1821.e1. doi:10.1016/j.clinthera.2015.05.505
   PubMed Web of Science ®Google Scholar
• Harmon G, Lefante J, Krousel-Wood M. Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications. Curr Opin Cardiol. 2006;21(4):310–315. doi:10.1097/01.hco.0000231400.10104.e2
   PubMed Web of Science ®Google Scholar
• Elnaem MH, Fatin R, Alhifany AA, Elrggal ME, Cheema E. Impact of pharmacist-led interventions on medication adherence and clinical outcomes in patients with hypertension and hyperlipidemia: a scoping review of published literature. J Multidiscip Health. 2020;635–645. doi:10.2147/JMDH.S257273
   Web of Science ®Google Scholar